Monoclonal antibodies were the largest sub-category, accounting for approximately half of the global biotechnology market in 2009. Hormones such as insulin & analogs, human growth hormone, and follicle stimulating hormone were the second largest sub-category. Growth factors, including erythropoietin and granulocyte colony stimulating factors were the third largest sub-category. Interferons, comprising of interferons alpha and beta were the fourth largest sub-category. The fifth in order were coagulation factors such as blood factors and coagulants. The last two sub-categories were of therapeutic enzymes and recombinant vaccines.
Highlights of the report
Roche was the leading biotechnology company in the world generating $33bn in sales in 2009, at a Y-o-Y growth of 8.2% and a market share of 35.4%.
The global biotechnology market generated $94.7bn in 2009 sales, demonstrating a Y-o-Y growth of 10
Copyright©2010 PR Newswire.
All rights reserved